Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah M Anderson

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|February 5, 2020
Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of <i>Yersinia pestis</i>Joshua L Willix, Jacob L Stockton, Rachel M Olson, et al.
Veterinary Parasitology, Regional Studies and Reports|January 24, 2025
Detection of Amblyomma maculatum and Rickettsia parkeri in prairies of Central MissouriJaylon Vaughn, Haylie J Brown, Anthony Ogunbadewa, et al.
Toxins|January 20, 2022
Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT<sup>®</sup>) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety ReviewGeraldine S Parrera, Hugo Astacio, Priya Tunga, et al.
Plos Pathogens|May 2, 2013
Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plagueKristen N Peters, Miqdad O Dhariwala, Jennifer M Hughes Hanks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2019
Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United StatesJason S Richardson, Geraldine S Parrera, Hugo Astacio, et al.
Plos One|November 8, 2019
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent productDeborah M Anderson, Veena R Kumar, Diana L Arper, et al.
Frontiers in Cellular and Infection Microbiology|December 11, 2012
Host stress and immune responses during aerosol challenge of Brown Norway rats with Yersinia pestisSusan T Gater, Kristen N Peters, Andrew G Kocsis, et al.
The American Journal of Tropical Medicine and Hygiene|October 5, 2021
Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus ImmunoglobulinJane White, Priya Tunga, Deborah M Anderson, et al.
Pathogens and Disease|April 11, 2014
Remote monitoring of the progression of primary pneumonic plague in Brown Norway rats in high-capacity, high-containment housingEric A Coate, Andrew G Kocsis, Kristen N Peters, et al.
Infection and Immunity|July 28, 2022
Protection Induced by Oral Vaccination with a Recombinant <i>Yersinia pseudotuberculosis</i> Delivering <i>Yersinia pestis</i> LcrV and F1 Antigens in Mice and Rats against Pneumonic PlagueSaugata Majumder, Rachel M Olson, Amit Singh, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|February 5, 2020
Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of <i>Yersinia pestis</i>Joshua L Willix, Jacob L Stockton, Rachel M Olson, et al.
Veterinary Parasitology, Regional Studies and Reports|January 24, 2025
Detection of Amblyomma maculatum and Rickettsia parkeri in prairies of Central MissouriJaylon Vaughn, Haylie J Brown, Anthony Ogunbadewa, et al.
Toxins|January 20, 2022
Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT<sup>®</sup>) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety ReviewGeraldine S Parrera, Hugo Astacio, Priya Tunga, et al.
Plos Pathogens|May 2, 2013
Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plagueKristen N Peters, Miqdad O Dhariwala, Jennifer M Hughes Hanks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2019
Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United StatesJason S Richardson, Geraldine S Parrera, Hugo Astacio, et al.
Plos One|November 8, 2019
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent productDeborah M Anderson, Veena R Kumar, Diana L Arper, et al.
Frontiers in Cellular and Infection Microbiology|December 11, 2012
Host stress and immune responses during aerosol challenge of Brown Norway rats with Yersinia pestisSusan T Gater, Kristen N Peters, Andrew G Kocsis, et al.
The American Journal of Tropical Medicine and Hygiene|October 5, 2021
Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus ImmunoglobulinJane White, Priya Tunga, Deborah M Anderson, et al.
Pathogens and Disease|April 11, 2014
Remote monitoring of the progression of primary pneumonic plague in Brown Norway rats in high-capacity, high-containment housingEric A Coate, Andrew G Kocsis, Kristen N Peters, et al.
Infection and Immunity|July 28, 2022
Protection Induced by Oral Vaccination with a Recombinant <i>Yersinia pseudotuberculosis</i> Delivering <i>Yersinia pestis</i> LcrV and F1 Antigens in Mice and Rats against Pneumonic PlagueSaugata Majumder, Rachel M Olson, Amit Singh, et al.
Pageof 5